Researchers at Yale University in a small, yet to be published study found that Covid vaccines were linked to a rare ...

In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high ...

Stephanie Mauro, now 76 years old, has had multiple sclerosis for more than 40 years. In 2020, when COVID-19 first appeared in the United States, her condition had worsened to the point where her ...

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...

Lina Nielsen was diagnosed with MS aged 17 and initially feared her athletics dreams were over due to her lack of education ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...

Findings show accumulation of neuronal injury and functional decline. HealthDay News — The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, ...

The "personalized cancer vaccines" used by the nine patients in the trial ... a new study finds. Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of ...

1 Most commonly, SC2Vs trigger immunological diseases, most likely due to dysregulation of the immune response to the vaccine. 2 One of the immunological neurological diseases that can be triggered by ...

Personalized cancer vaccines showed significant immune responses in stage III/IV renal cell carcinoma patients, with T-cells increasing 166-fold and persisting for up to three years. The vaccine ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...